Beauty brand McPherson’s denies ASIC case over Dr LeWinn sales forecast

ASIC 2023-03-28 9:49 pm By Sam Matthews | Melbourne

Please login to bookmark

Beauty giant McPherson’s has denied ASIC’s claims that it misled the market and breached its disclosure obligations in 2020, arguing that a document showing sales of its Dr LeWinn’s line were down by $21 million was a draft that couldn’t have been used to revise a financial forecast.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au